NASDAQ:KMDA
Kamada Ltd. Stock News
$5.30
-0.120 (-2.21%)
At Close: May 21, 2024
Kamada Reports Fourth Quarter and Fiscal Year 2020 Financial Results, Recent Achievements and Corporate Development Activities
07:00am, Wednesday, 10'th Feb 2021
REHOVOT, Israel, Feb. 10, 2021 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a plasma-derived biopharmaceutical company, today announced financial results for the three and 12 months
Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2020 Financial Results, and Host Conference Call on February 10, 2021
07:00am, Wednesday, 03'rd Feb 2021
REHOVOT, Israel, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), plasma-derived biopharmaceutical company, today announced that it will release financial results for the fourth qu
Kamada Acquires FDA-Licensed Plasma Collection Center from Blood and Plasma Research, Inc. in Texas, USA
07:00am, Monday, 01'st Feb 2021
Transaction Represents Kamada's Entry into U.S. Plasma Collection Market and Advances the Company's Strategic Objective to Evolve into a Fully Integrated Specialty Plasma Company
American BriVision: Deep Dive Into Market Potential
03:38pm, Thursday, 14'th Jan 2021
American BriVision: Deep Dive Into Market Potential
Kamada Selected as a Winner of the Genesis Prize Foundation and Start-Up Nation Central Competition
07:00am, Tuesday, 05'th Jan 2021
Award Recognizes Israeli Companies Working to Combat Coronavirus and the Damage of Future Pandemics Award Recognizes Israeli Companies Working to Combat Coronavirus and the Damage of Future Pandemics
Kamada Added to the NASDAQ Biotechnology Index
07:00am, Monday, 21'st Dec 2020
REHOVOT, Israel, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a plasma-derived biopharmaceutical company, today announced that it has been selected for addition to the
Kamada Ltd. (KMDA) CEO Amir London on Q3 2020 Results - Earnings Call Transcript
02:51pm, Wednesday, 11'th Nov 2020
Kamada Ltd. (KMDA) CEO Amir London on Q3 2020 Results - Earnings Call Transcript
Kamada: Q3 Earnings Insights
07:17am, Wednesday, 11'th Nov 2020
Shares of Kamada (NASDAQ:KMDA) were unchanged after the company reported Q3 results. Quarterly Results Earnings per share rose 7.14% over the past year to $0.15, which beat the estimate of $0.06.
Kamada to Announce Third Quarter Ended September 30, 2020 Financial Results and Host Conference Call on November 11, 2020
07:00am, Wednesday, 04'th Nov 2020
REHOVOT, Israel, Nov. 04, 2020 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ & TASE: KMDA), plasma-derived biopharmaceutical company, today announced that it will release financial results for the third qua
Kamada Looks Cheap AS Takeda Deal Creates Value
02:11pm, Monday, 02'nd Nov 2020
We believe Kamada looks cheap, as there are long-tailed asset returns from the Takeda deal which the market may be overlooking. Recent retraction in Kamada's shares on the charts signals a potential d
* The Study of KEDRAB® (Rabies Immune Globulin [Human]) Conducted in Children was the First and Only Pediatric Study for any HRIG Available in U.S. * The Study Met its Primary Objective, Which Was t
What Does Kamada's Debt Look Like?
01:34pm, Friday, 14'th Aug 2020
Over the past three months, shares of Kamada Inc. (NASDAQ: KMDA) increased by 67.51%. Before having a look at the importance of debt, let's look at how much debt Kamada has.Kamada's Debt According to
Kamada Ltd (KMDA) Q2 2020 Earnings Call Transcript
09:30pm, Wednesday, 12'th Aug 2020
Image source: The Motley Fool. Kamada Ltd (NASDAQ: KMDA)Q2 2020 Earnings CallAug 12, 2020, 8:30 a.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: Operato
Kamada (KMDA) Q2 Earnings and Revenues Lag Estimates
12:35pm, Wednesday, 12'th Aug 2020
Kamada (KMDA) delivered earnings and revenue surprises of -25.00% and -4.40%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Kamada Announces Changes to its Board of Directors
11:30am, Wednesday, 12'th Aug 2020
* Lilach Asher Topilsky, a Director on the Company’s Board and a Senior Partner at FIMI Opportunity Funds, Appointed Chairman * Current Chairman, Leon Recanati, Remains on the Board as a Director